Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jaba Recordati is a leading Portuguese pharmaceutical company and a subsidiary of the international Recordati Group. Founded in 1927 and acquired by Recordati in 2006, the company focuses on the commercialization and distribution of a wide range of pharmaceutical products, including prescription drugs and over-the-counter (OTC) medicines. Its portfolio covers diverse therapeutic areas such as cardiovascular health, central nervous system disorders, urology, and gastroenterology. Jaba Recordati operates a significant manufacturing facility in Portugal and serves as a key hub for the group's operations in the Iberian Peninsula and Portuguese-speaking African countries. The company is well-known for established brands like Guronsan and Transact Lat.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jaba Farmacêutica.